Center-Authored Papers

Filters: Author is Hughes, James P  [Clear All Filters]
2008
Kratz M, Purnell JQ, Breen PA, Thomas KK, Utzschneider KM, Carr DB, Kahn SE, Hughes JP, Rutledge EA, Van Yserloo B et al..  2008.  Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.. The Journal of clinical endocrinology and metabolism. 93(3):959-66. Abstract
2009
Edelstein ZR, Madeleine MM, Hughes JP, Johnson LG, Schwartz SM, Galloway DA, Carter JJ, Koutsky LA.  2009.  Age of diagnosis of squamous cell cervical carcinoma and early sexual experience.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 18(4):1070-6. Abstract
Winer RL, Harris TG, Xi L, Jansen KU, Hughes JP, Feng Q, Welebob C, Ho J, Lee S-K, Carter JJ et al..  2009.  Quantitative human papillomavirus 16 and 18 levels in incident infections and cervical lesion development.. Journal of medical virology. 81(4):713-21. Abstract
Rowhani-Rahbar A, Carter JJ, Hawes SE, Hughes JP, Weiss NS, Galloway DA, Koutsky LA.  2009.  Antibody responses in oral fluid after administration of prophylactic human papillomavirus vaccines.. The Journal of infectious diseases. 200(9):1452-5. Abstract
2010
Lingappa JR, Hughes JP, Wang RS, Baeten JM, Celum C, Gray GE, Stevens WS, Donnell D, Campbell MS, Farquhar C et al..  2010.  Estimating the impact of plasma HIV-1 RNA reductions on heterosexual HIV-1 transmission risk.. PloS one. 5(9):e12598. Abstract
Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A et al..  2010.  Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women.. Journal of acquired immune deficiency syndromes (1999). 53(5):606-13. Abstract
Fuchs J, Celum C, Wang J, Hughes JP, Sanchez J, Cowan F, Reid S, Delany-Moretlwe S, Corey L, Wald A.  2010.  Clinical and virologic efficacy of herpes simplex virus type 2 suppression by acyclovir in a multicontinent clinical trial.. The Journal of infectious diseases. 201(8):1164-8. Abstract
Donnell D, Hughes JP, Fleming TR.  2010.  Challenges in the design of HIV prevention trials in the United States.. Journal of acquired immune deficiency syndromes (1999). 55 Suppl 2:S136-40. Abstract
Celum C, Wald A, Lingappa JR, Magaret AS, Wang RS, Mugo N, Mujugira A, Baeten JM, Mullins JI, Hughes JP et al..  2010.  Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.. The New England journal of medicine. 362(5):427-39. Abstract
Lingappa JR, Baeten JM, Wald A, Hughes JP, Thomas KK, Mujugira A, Mugo N, Bukusi EA, Cohen CR, Katabira E et al..  2010.  Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.. Lancet. 375(9717):824-33. Abstract
Kim HN, Wang J, Hughes JP, Coombs R, Sanchez J, Reid S, Delany-Moretlwe S, Cowan F, Fuchs J, Eshleman SH et al..  2010.  Effect of acyclovir on HIV-1 set point among herpes simplex virus type 2-seropositive persons during early HIV-1 infection.. The Journal of infectious diseases. 202(5):734-8. Abstract
2011
Bernabe-Ortiz A, Carcamo CP, Scott JD, Hughes JP, Garcia PJ, Holmes KK.  2011.  HBV infection in relation to consistent condom use: a population-based study in Peru.. PloS one. 6(9):e24721. Abstract
Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W et al..  2011.  Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial.. PloS one. 6(3):e16986. Abstract
Eshleman SH, Hudelson SE, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF et al..  2011.  Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial.. The Journal of infectious diseases. 204 (12):1918-1926. Abstract
Jacob ST, Baeten JM, Hughes JP, Peinado J, Wang J, Sanchez J, Reid SE, Delany-Moretlwe S, Cowan F, Fuchs JD et al..  2011.  A post-trial assessment of factors influencing study drug adherence in a randomized biomedical HIV-1 prevention trial.. AIDS and behavior. 15(5):897-904. Abstract
Xi L, Hughes JP, Castle PE, Edelstein ZR, Wang C, Galloway DA, Koutsky LA, Kiviat NB, Schiffman M.  2011.  Viral load in the natural history of human papillomavirus type 16 infection: a nested case-control study.. The Journal of infectious diseases. 203(10):1425-33. Abstract
2012
Murnane PM, Hughes JP, Celum C, Lingappa JR, Mugo N, Farquhar C, Kiarie J, Wald A, Baeten JM.  2012.  Using plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.. PloS one. 7(11):e51192. Abstract
Hughes JP, Baeten JM, Lingappa JR, Magaret AS, Wald A, de Bruyn G, Kiarie J, Inambao M, Kilembe W, Farquhar C et al..  2012.  Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1-Serodiscordant Couples.. The Journal of infectious diseases. 205(3):358-365. Abstract
García PJ, Holmes KK, Cárcamo CP, Garnett GP, Hughes JP, Campos PE, Whittington WLH.  2012.  Prevention of sexually transmitted infections in urban communities (Peru PREVEN): a multicomponent community-randomised controlled trial.. Lancet. Abstract
Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A et al..  2012.  Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial.. Sexually transmitted diseases. 39(1):21-4. Abstract
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L et al..  2012.  Acyclovir achieves lower concentration in African HIV-seronegative, HSV-2 seropositive women compared to non-African populations.. Antimicrobial agents and chemotherapy. 56(5):2777-9. Abstract
Wolfrum SG, Koutsky LA, Hughes JP, Feng Q, Xi L, Shen Z, Winer RL.  2012.  Evaluation of dry and wet transport of at-home self-collected vaginal swabs for human papillomavirus testing.. Journal of medical microbiology. 61(Pt 11):1538-45. Abstract
Winer RL, Hughes JP, Feng Q, Xi L, Lee S-K, O'Reilly SF, Kiviat NB, Koutsky LA.  2012.  Prevalence and risk factors for oncogenic human papillomavirus infections in high-risk mid-adult women.. Sexually transmitted diseases. 39(11):848-56. Abstract
Edelstein ZR, Schwartz SM, Hawes S, Hughes JP, Feng Q, Stern ME, O'Reilly S, Lee S-K, Xi L, Koutsky LA.  2012.  Rates and determinants of oral human papillomavirus infection in young men.. Sexually transmitted diseases. 39(11):860-7. Abstract
Kahle EM, Hughes JP, Lingappa JR, John-Stewart G, Celum C, Nakku-Joloba E, Njuguna S, Mugo N, Bukusi E, Manongi R et al..  2012.  An empiric risk scoring tool for identifying high-risk heterosexual HIV-1 serodiscordant couples for targeted HIV-1 prevention.. Journal of acquired immune deficiency syndromes (1999). Abstract